Thermo Fisher Scientific Inc.
TMO
$590.83
-$2.42-0.41%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.22% | 2.04% | 0.96% | 0.05% | -2.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.22% | 2.05% | 0.96% | 0.05% | -2.42% |
| Cost of Revenue | 2.35% | 1.35% | -0.53% | -2.07% | -3.78% |
| Gross Profit | 4.49% | 3.06% | 3.13% | 3.22% | -0.39% |
| SG&A Expenses | -0.51% | -0.27% | 0.75% | 2.58% | 0.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -4,500.00% | -4,500.00% | -4,500.00% | -4,500.00% | -- |
| Total Operating Expenses | 1.64% | 1.05% | -0.11% | -0.87% | -2.76% |
| Operating Income | 10.66% | 6.63% | 5.92% | 4.40% | -0.80% |
| Income Before Tax | 5.26% | 3.51% | 7.32% | 12.17% | 8.26% |
| Income Tax Expenses | -15.13% | -26.72% | -9.06% | 131.69% | 97.84% |
| Earnings from Continuing Operations | 7.40% | 6.42% | 8.74% | 6.47% | 3.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -135.71% | -100.00% | -110.26% | -110.00% | -22.22% |
| Net Income | 7.07% | 5.84% | 7.97% | 5.69% | 3.28% |
| EBIT | 10.66% | 6.63% | 5.92% | 4.40% | -0.80% |
| EBITDA | 3.65% | 0.64% | 0.39% | 0.33% | -2.47% |
| EPS Basic | 8.26% | 7.03% | 9.19% | 6.87% | 4.36% |
| Normalized Basic EPS | 12.18% | 8.00% | 7.11% | 8.06% | 2.52% |
| EPS Diluted | 8.51% | 7.24% | 9.36% | 6.99% | 4.69% |
| Normalized Diluted EPS | 12.46% | 8.14% | 7.25% | 8.12% | 2.65% |
| Average Basic Shares Outstanding | -1.11% | -1.11% | -1.10% | -1.10% | -1.03% |
| Average Diluted Shares Outstanding | -1.36% | -1.23% | -1.23% | -1.16% | -1.16% |
| Dividend Per Share | 10.53% | 10.81% | 11.11% | 11.43% | 12.59% |
| Payout Ratio | 0.02% | 0.04% | 0.02% | 0.05% | 0.10% |